Journal ArticleOPEN ACCESS

Eculizumab in Severe Shiga-Toxin–Associated HUS

  • Lapeyraque A
  • Malina M
  • Fremeaux-Bacchi V
  • et al.
New England Journal of Medicine (2011) 364(26) 2561-2563
DOI: 10.1056/nejmc1100859
374Citations
Citations of this article
156Readers
Mendeley users who have this article in their library.

Abstract

This letter reports treatment of three children with severe, dialysis-requiring Shiga-toxin–induced hemolytic–uremic syndrome (HUS) with eculizumab, a monoclonal anti-C5 antibody. The condition of all three children improved rapidly.

Cite

CITATION STYLE

APA

Lapeyraque, A.-L., Malina, M., Fremeaux-Bacchi, V., Boppel, T., Kirschfink, M., Oualha, M., … Schaefer, F. (2011). Eculizumab in Severe Shiga-Toxin–Associated HUS. New England Journal of Medicine, 364(26), 2561–2563. https://doi.org/10.1056/nejmc1100859

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free